These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34427044)

  • 21. Effect of Infliximab on Chronic Progressive Neuro-Behçet's Disease: Influence of the Timing of Introduction on the Patient Outcome.
    Hirohata S; Kikuchi H; Sawada T; Kuwana M; Kawachi I; Kirino Y; Ishigatsubo Y; Takeno M
    Intern Med; 2024 Feb; 63(4):481-486. PubMed ID: 37344428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
    Buggage RR; Levy-Clarke G; Sen HN; Ursea R; Srivastava SK; Suhler EB; Altemare C; Velez G; Ragheb J; Chan CC; Nussenblatt RB; Bamji AT; Sran P; Waldmann T; Thompson DJ
    Ocul Immunol Inflamm; 2007; 15(2):63-70. PubMed ID: 17558830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical presentation of Behçet's disease with central nervous system involvement successfully treated with infliximab.
    Studer U; Ruehe B; Waldegg G; Vajtai I; Escher R; Aeberli D
    Rheumatol Int; 2012 May; 32(5):1431-5. PubMed ID: 21445544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SER recommendations on treatment of refractory Behçet's syndrome.
    Moriano Morales C; Graña Gil J; Brito García N; Martín Varillas JL; Calvo Del Río V; Moya Alvarado P; Narváez García FJ; Espinosa G; Díaz Del Campo Fontecha P; Guerra Rodríguez M; Mateo Arranz J; López Gómez M; Francisco Hernández FM; Trujillo MM; Dos Santos Sobrín R; Martín Sánchez JI; Maese Manzano J; Suárez Cuba J
    Reumatol Clin (Engl Ed); 2024 Apr; 20(4):204-217. PubMed ID: 38614885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological manifestations of Behçet's disease: Study of 57 patients.
    Toledo-Samaniego N; Galeano-Valle F; Ascanio-Palomares P; González-Martínez B; Valencia-Kruszyna A; Demelo-Rodríguez P
    Med Clin (Barc); 2020 Jun; 154(12):488-492. PubMed ID: 31924326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and safety of infliximab in the treatment of Behçet's disease.
    Capella MJ; Foster CS
    Ocul Immunol Inflamm; 2012 Jun; 20(3):198-202. PubMed ID: 22486265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Outcomes and Predictors of Sustained Response in Patients with Intestinal Behcet's Disease Treated with Infliximab.
    Zou J; Ji DN; Cai JF; Guan JL; Bao ZJ
    Dig Dis Sci; 2017 Feb; 62(2):441-447. PubMed ID: 28044230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of neuro-Behçet's disease: an update.
    Borhani Haghighi A
    Expert Rev Neurother; 2009 Apr; 9(4):565-74. PubMed ID: 19344307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between the parenchymal neurological involvement and posterior uveitis in Behçet's syndrome.
    Bitik B; Tufan A; Sahin K; Sucullu Karadag Y; Can Sandikci S; Mercan R; Ak F; Karaaslan Y; Ozturk MA; Goker B; Haznedaroglu S
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):82-85. PubMed ID: 27791948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute Neuro-Behçet's Disease].
    Takeuchi H
    Brain Nerve; 2021 May; 73(5):560-567. PubMed ID: 34006689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.
    Mora P; Menozzi C; Orsoni JG; Rubino P; Ruffini L; Carta A
    Orphanet J Rare Dis; 2013 Jan; 8():18. PubMed ID: 23360593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological therapy for ocular Behçet's disease with off-label drug prescription in Turkey.
    Citirik M; Ucgul Atilgan C; Rahmanlar H; Alkan A; Gursoz H
    Eur J Hosp Pharm; 2023 Jan; 30(1):53-56. PubMed ID: 34083220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.
    Handa T; Tsunekawa H; Yoneda M; Watanabe D; Mukai T; Yamamura M; Iwaki M; Zako M
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S58-63. PubMed ID: 21968238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases.
    Shugaiv E; Tüzün E; Mutlu M; Kiyat-Atamer A; Kurtuncu M; Akman-Demir G
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S64-7. PubMed ID: 21968239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis.
    Imabayashi K; Ayano M; Higashioka K; Yokoyama K; Yamamoto K; Takayama K; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    J Neuroimmunol; 2021 Aug; 357():577631. PubMed ID: 34153801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole thoracal spinal cord involvement in case of neuro-Behçet's disease.
    Kabukçu T; Edemci S; Uçan H; Celik C; Gunes HN; Yoldas T
    Rheumatol Int; 2009 Apr; 29(6):707-9. PubMed ID: 18982328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of patients with Behçet's disease during the COVID-19 pandemic.
    Dursun R; Temiz SA; Özer İ; Daye M; Ataseven A
    Dermatol Ther; 2020 Nov; 33(6):e14063. PubMed ID: 32710599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course of patients with Behçet's uveitis following discontinuation of infliximab therapy.
    Kawaguchi T; Kawazoe Y; Kamoi K; Miyanaga M; Takase H; Sugita S; Mochizuki M
    Jpn J Ophthalmol; 2014 Jan; 58(1):75-80. PubMed ID: 24129677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.